Package 71335-2808-1

{"route": ["ORAL"], "spl_id": "6bbfdbeb-02d5-4be9-b6b3-b6fd9c97e1c9", "openfda": {"nui": ["N0000185008", "N0000185007", "N0000182137", "N0000190114", "N0000185503"], "unii": ["MVR3JL3B2V"], "rxcui": ["1300801"], "spl_set_id": ["00826723-d25e-498a-b8d4-d17e5c14dda5"], "pharm_class_epc": ["beta3-Adrenergic Agonist [EPC]"], "pharm_class_moa": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (71335-2808-1)  / 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE", "package_ndc": "71335-2808-1", "marketing_start_date": "20250926"}], "brand_name": "MIRABEGRON", "product_id": "71335-2808_6bbfdbeb-02d5-4be9-b6b3-b6fd9c97e1c9", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta3-Agonists [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "beta3-Adrenergic Agonist [EPC]"], "product_ndc": "71335-2808", "generic_name": "mirabegron", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "MIRABEGRON", "active_ingredients": [{"name": "MIRABEGRON", "strength": "50 mg/1"}], "application_number": "ANDA209485", "marketing_category": "ANDA", "marketing_start_date": "20240903", "listing_expiration_date": "20261231"}